A postmarketing study of relative abuse liability of hypnotic sedative drugs

Addiction

Volumn 99, Issue 2, 2004, Pages 165-173

  Jaffe, Jerome H ^a   Bloor, Roger ^b   Crome, Ilana ^b   Carr, Malcolm ^c   Alam, Farrukh ^c   Simmons, Arnol ^d   Meyer, Roger E ^d  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b KEELE UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^c Best Practice ^*  (United Kingdom)

^d Best Practice Project Management Inc   (United States)

Author keywords

Benzodiazepine drugs; GABAA agonists; Non benzodiazepine hypnotics; Postmarketing data; Relative abuse liability

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; BENZODIAZEPINE DERIVATIVE; CHLORPHENIRAMINE; DIAZEPAM; DIPHENHYDRAMINE; FLUOXETINE; HYPNOTIC SEDATIVE AGENT; NITRAZEPAM; NOREX; TEMAZEPAM; TRAZODONE; UNCLASSIFIED DRUG; ZOLPIDEM; ZOPICLONE;

ADDICTION; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; DRUG ABUSE; DRUG DEPENDENCE; DRUG SCREENING; DRUG SURVEILLANCE PROGRAM; HEALTH SURVEY; HUMAN; INFORMATION PROCESSING; INSURANCE; MAJOR CLINICAL STUDY; POSTMARKETING SURVEILLANCE; REVIEW; SCORING SYSTEM; UNITED KINGDOM;

CLUSTER ANALYSIS; FEMALE; GREAT BRITAIN; HUMANS; HYPNOTICS AND SEDATIVES; MALE; MARKETING; PILOT PROJECTS; PRODUCT SURVEILLANCE, POSTMARKETING; SUBSTANCE-RELATED DISORDERS;

EID: 1342322732     PISSN: 09652140     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2003.00631.x     Document Type: Review

References (25)

1. Aronson, M. D. & Hafez, H. (1986) A case of trazodone-induced ventricular tachycardia. Journal of Clinical Psychiatry, 47, 388-389.
2. Babor, T. F. & Brown, J. & Del Boca, F. (1990) Validity of self-reports in applied research on addictive behaviors: fact or fiction? Behavioral Assessment, 12, 5-31.
3. Beaini, A. Y. & Johnson, T. S., Langstaff, P., Carr, M. P., Crossfield, J. N. & Sweeney, R. C. (2000) A compressed opiate detoxification regime with naltrexone maintenance: patient tolerance, risk assessment and abstinence rates. Addiction Biology, 5, 451-462.
4. Busto, U., Sellers, E. M., Naranjo, C. A., Cappell, H. D., Sanchez-Craig, M. & Simpkins, J. (1986) Patterns of benzodiazepine abuse and dependence. British Journal of Addiction, 81, 8 7-94.
5. Evans, S. M., Funderburk, F. R. & Griffiths, R. R. (1990) Zolpidem and triazolam in humans. Behavioral and subjective effects and abuse liability. Journal of Pharmacology and Experimental Therapeutics, 255, 1246-1255.
6. Griffiths, R. R., Sannerud, C. A., Ator, N. A. & Brady, J. V. (1992) Zolpidem behavioral pharmacology in baboons: self-Injection, discrimination, tolerance and withdrawal. Journal of Pharmacology and Experimental Therapeutics, 260, 1199-1208.
7. Griffiths, R. R. & Scannerud, C. A. (1987) Abuse of and dependence on benzodiazepines and other anxiolytic/sedative drugs. In: Meltzer, H. Y., ed. Psychopharmacology: the Third Generation of Progress, pp. 1535-1541. New York: Raven Press.
8. Griffiths, R. R. & Wolf, B. (1990) Relative abuse liability of different benzodiazepines in drug abusers. Journal of Clinical Pharmacology, 10, 237-243.
9. Iguchi, M. Y., Handelsman, L., Bickel, W. K. & Griffiths, R. R. (1993) Benzodiazepine and sedative use/abuse by methadone maintenance clients. Drug and Alcohol Dependence, 32, 257-266.
10. Janowsky, D., Curtis, G., Zisook, S. & Kuhn, R. & Resovsky, K. (1983) Ventricular arrythmias possibly aggravated by trazodone. American Journal of Psychiatry, 140, 796-797.
11. Knisely, J. S., Campbell, E. D., Dawson, K. S. & Schnoll, S. H. (2002) Drug and Alcohol Dependence, 68, 15-22.
12. Margolese, H. & Chouinard, G. (2000) Serotonin syndrome from addition of low-dose trazodone to nefazodone. American Journal of Psychiatry, 157, 1022-1022.
13. Mendelson, W. B., Roth, T., Cassella, J., Roehrs, T., Walsh, J. K., Woods, J. H., Buysse, D. J. & Meyer, R. E. (2003) Conference report. The treatment of chronic insomnia: drug indications, chronic use and abuse liability. NCDEU Meeting, Phoenix, Arizona, 28 May 2001. Sleep Medicine Reviews, in press.
14. National Disease and Therapeutic Index (1997) Plymouth Meeting PA: IMS America Ltd.
15. Rausch, J. L. & Pavlinac, D. M. & Newman, P. E. (1984) Complete heart block following a,single dose of trazodone. American Journal of Psychiatry, 141, 1472-1473.
16. Roehrs, T. & Roth, T. (2001) Sleep, sleepiness, sleep disorders and alcohol use and abuse. Sleep Medicine Reviews, 5, 287-297.
17. Saletu-Zyhlarz, G. M., Abu-Bakr, M. H., Anderer, P., Gruber, G., Mandl, M., Strobl, R., Gollner, D., Prause, W. & Saletu, B. (2002) Insomnia in depression: differences in objective and subjective sleep and awakening quality to normal controls. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 26, 249-260.
18. Stitzer, M. L., Griffiths, R. R., McLellan, A. T., Grabowski, J. & Hawthorne, J. W. (1981) Diazepam use among methadone maintenance patients: patterns and dosages. Drug and Alcohol Dependence, 8, 189-199.
19. Walsh, J. K., Erman, M., Erwin, C. W., Jamieson, A., Mahowald, M., Regestein, Q., Scharf, M., Tigel, P. & Vogel, G. & Ware, J. C. (1998) Subjective hypnotic efficacy of trazodone and zolpidem in DSM-III-R primary insomnia. Human Psychopharmacology, 13, 191-198.
20. Walsh, J. K. & Schweitzer, P. K. (1999) Ten-year trends in the pharmacological treatment of insomnia. Sleep, 22, 371-375.
21. Woods, J. H. (1998) Problems and opportunities in regulation of benzodiazepines. Journal of Clinical Pharmacology, 38, 773-782.
22. Woods, J. H., Katz, J. L. & Winger, G. (1987) Abuse liability of benzodiazepines. Pharmacology Reviews, 39, 251-413.
23. Woods, J. H. & Winger, G. (1995) Current benzodiazepine issues. Psychopharmacology, 118, 107-115.
24. World Health Organization Expert Committee on Drug Dependence (2001) Thirty-Second Report, Technical Report Series no. 903 030501, p. 31. Geneva: Switzerland.
25. Zalma, A., von Moltke, L. L., Granda, B. W., Harmatz, J. S. & Shader, R. I. & Greenblatt, D. J. (2000) In vitro metabolism of trazodone by CYP3A: inhibition by ketoconazole and human immunodeficiency viral protease inhibitors. Biological Psychiatry, 47, 655-661.